TRANSFERRING TO INSULIN DETEMIR FROM NPH INSULIN OR INSULIN GLARGINE IN TYPE 2 DIABETES PATIENTS ON BASAL-ONLY THERAPY WITH ORAL ANTIDIABETIC DRUGS IMPROVES GLYCAEMIC CONTROL AND REDUCES WEIGHT GAIN AND RISK OF HYPOGLYCAEMIA: 14-WEEK FOLLOW-UP DATA FROM PREDICTIVE

DORNHORST, A., LUDDEKE, H.J., & KOENEN, C.. (2008). TRANSFERRING TO INSULIN DETEMIR FROM NPH INSULIN OR INSULIN GLARGINE IN TYPE 2 DIABETES PATIENTS ON BASAL-ONLY THERAPY WITH ORAL ANTIDIABETIC DRUGS IMPROVES GLYCAEMIC CONTROL AND REDUCES WEIGHT GAIN AND RISK OF HYPOGLYCAEMIA: 14-WEEK FOLLOW-UP DATA FROM PREDICTIVE. DIABETES OBESITY AND METABOLISM, 10(1), 75-81. SID. https://sid.ir/paper/637286/en

DORNHORST A., LUDDEKE H.J., KOENEN C.. TRANSFERRING TO INSULIN DETEMIR FROM NPH INSULIN OR INSULIN GLARGINE IN TYPE 2 DIABETES PATIENTS ON BASAL-ONLY THERAPY WITH ORAL ANTIDIABETIC DRUGS IMPROVES GLYCAEMIC CONTROL AND REDUCES WEIGHT GAIN AND RISK OF HYPOGLYCAEMIA: 14-WEEK FOLLOW-UP DATA FROM PREDICTIVE. DIABETES OBESITY AND METABOLISM[Internet]. 2008;10(1):75-81. Available from: https://sid.ir/paper/637286/en

A. DORNHORST, H.J. LUDDEKE, and C. KOENEN, “TRANSFERRING TO INSULIN DETEMIR FROM NPH INSULIN OR INSULIN GLARGINE IN TYPE 2 DIABETES PATIENTS ON BASAL-ONLY THERAPY WITH ORAL ANTIDIABETIC DRUGS IMPROVES GLYCAEMIC CONTROL AND REDUCES WEIGHT GAIN AND RISK OF HYPOGLYCAEMIA: 14-WEEK FOLLOW-UP DATA FROM PREDICTIVE,” DIABETES OBESITY AND METABOLISM, vol. 10, no. 1, pp. 75–81, 2008, [Online]. Available: https://sid.ir/paper/637286/en